Synonyms/Common Names/Related Substances:
- Advanced Ambrotose®, Ambrotose® complex, dietary saccharide, fucose, galactose, glucose, Glycentials®, glycobiology, glycoconjugates, glycoform, glyconutritional, glycoprotein, High Purity D-Ribose™, Manapol®, mannose, N-acetylgalactosamine, N-acetylglucosamine, N-acetylneuraminic acid, saccharide, sialic acid, sugars, sugars that heal, xylose, Xylotene™.
- Note: This review does discuss clinical studies of individual glyconutrients in detail.
Clinical Bottom Line/Effectiveness
Brief Background:
- In humans, eight monosaccharides (carbohydrates: glucose, galactose, mannose, fucose, xylose, N-acetylglucosamine, N-acetylgalactosamine, and N-acetylneuraminic acid) are required for the synthesis of glycoproteins, and it is claimed that only two of these sugars (glucose and galactose) are readily found in a normal diet. Dietary supplements that supply sources of all of these sugars are known as glyconutrients.
- Supplementation with glyconutrients is not typically disease specific, as these polysaccharides are thought to be critical to cellular communication. Theoretically, glyconutrients may be effective treatments for certain diseases caused by inborn errors of metabolism (1;2) as well as hexose malabsorption disorders, both congenital and bowel disease related (3).
- Glyconutrient research (glycobiology) and sales have escalated in the last few years, with a multilevel marketing (MLM) company called Mannatech a leading manufacturer of glyconutrient supplements that are marketed under the product line Ambrotose®. In 2009, the Texas attorney general prosecuted a leading manufacturer of glyconutrient supplements, citing the company's exaggeration of the product's benefits.
- Case studies and animal studies have studied glyconutrients' effects on conditions like cognition and cancer prevention. Clinical studies of glyconutrients' effects on attention-deficit hyperactivity disorder (ADHD), failure to thrive, and myasthenia gravis have been conducted as well. Further randomized controlled trials investigating the efficacy and cost-effectiveness of glyconutrient therapy are needed before firm conclusions may be drawn.
Dosing/Toxicology
- Content available for subscribers only.
Precautions/Contraindications
- Content available for subscribers only.
Interactions
Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements, drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments, or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.
- Content available for subscribers only.
Mechanism of Action
- Content available for subscribers only.
History
- Content available for subscribers only.
Evidence Table
- Content available for subscribers only.
Evidence Discussion
- Content available for subscribers only.
- Content available for subscribers only.
Author Information
- Content available for subscribers only.
References
Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
- Content available for subscribers only.
Copyright © 2012 Natural Standard. Commercial distribution or
reproduction prohibited.
The information in this monograph is intended for informational purposes
only, and is meant to help users better understand health concerns.
Information is based on review of scientific research data, historical
practice patterns, and clinical experience. This information should not be
interpreted as specific medical advice. Users should consult with a
qualified healthcare provider for specific questions regarding therapies,
diagnosis and/or health conditions, prior to making therapeutic decisions.